Regulation of ornithine decarboxylase during oncogenic transformation: Mechanisms and therapeutic potential

L. M. Shantz, V. A. Levin

Research output: Contribution to journalReview article

74 Scopus citations

Abstract

The activity of ornithine decarboxylase (ODC1), the first enzyme in polyamine biosynthesis, is induced during carcinogenesis by a variety of oncogenic stimuli. Intracellular levels of ODC and the polyamines are tightly controlled during normal cell growth, and regulation occurs at the levels of transcription, translation and protein degradation. Several known proto-oncogenic pathways appear to control ODC transcription and translation, and dysregulation of pathways downstream of ras and myc result in the constitutive elevation of ODC activity that occurs with oncogenesis. Inhibition of ODC activity reverts the transformation of cells in vitro and reduces tumor growth in several animal models, suggesting high levels of ODC are necessary for the maintenance of the transformed phenotype. The ODC irreversible inactivator DFMO has proven to be not only a valuable tool in the study of ODC in cancer, but also shows promise as a chemopreventive and chemotherapeutic agent in certain types of malignancies.

Original languageEnglish (US)
Pages (from-to)213-223
Number of pages11
JournalAmino Acids
Volume33
Issue number2
DOIs
StatePublished - Aug 1 2007

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Clinical Biochemistry
  • Organic Chemistry

Fingerprint Dive into the research topics of 'Regulation of ornithine decarboxylase during oncogenic transformation: Mechanisms and therapeutic potential'. Together they form a unique fingerprint.

  • Cite this